Recent advances in adjuvant immunotherapy are reshaping treatment prospects for early-stage melanoma patients. Tune in to this webcast of a presentation from the 2024 American Oncology Network Summit. Discussions include latest clinical evidence, assessment of current barriers, and development of actionable plans for effective translation of adjuvant immunotherapy into clinical practice for early-stage melanoma.This activity is delivered in partnership with the Melanoma Research Alliance.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/accelerating-incorporation-immunotherapy-into-early-stage-melanoma-across
- Start Date: 2024-06-28 05:00:00
- End Date: 2024-06-28 05:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 90000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest